Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoHealth (GOCO) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for GoHealth (GOCO) over the last 7 years, with Q3 2025 value amounting to 842.21%.

  • GoHealth's EBITDA Margin fell 8061300.0% to 842.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.68%, marking a year-over-year decrease of 301600.0%. This contributed to the annual value of 0.88% for FY2024, which is 102400.0% up from last year.
  • Latest data reveals that GoHealth reported EBITDA Margin of 842.21% as of Q3 2025, which was down 8061300.0% from 105.68% recorded in Q2 2025.
  • GoHealth's 5-year EBITDA Margin high stood at 20.63% for Q4 2024, and its period low was 842.21% during Q3 2025.
  • Moreover, its 5-year median value for EBITDA Margin was 28.76% (2023), whereas its average is 78.95%.
  • As far as peak fluctuations go, GoHealth's EBITDA Margin skyrocketed by 1974100bps in 2023, and later crashed by -8061300bps in 2025.
  • GoHealth's EBITDA Margin (Quarter) stood at 94.12% in 2021, then plummeted by -104bps to 191.97% in 2022, then soared by 103bps to 5.44% in 2023, then soared by 279bps to 20.63% in 2024, then tumbled by -4183bps to 842.21% in 2025.
  • Its EBITDA Margin was 842.21% in Q3 2025, compared to 105.68% in Q2 2025 and 3.02% in Q1 2025.